ArticleBMJ public health2026
Burden and determinants of self-reported non-communicable disease comorbidities among HIV positive adults in Tanzania: insights from the Tanzania HIV Impact Survey 2022-2023.
Article in BMJ public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: People living with HIV (PLWH) face an increased risk of developing comorbidities involving HIV and non-communicable diseases (NCDs) caused by a mix of modifiable and non-modifiable risk factors. This study aimed to quantify the burden of NCD-HIV comorbidities and examine their determinants among HIV-positive adults aged ≥15 years using data from the 2022-2023 Tanzania HIV Impact Survey (THIS). Methods: The 2022-2023 THIS enrolled 33 663 individuals who underwent HIV testing, of whom 1850 tested positive. Key variables, including socioeconomic, demographic and behavioural risk factors and clinical characteristics, were extracted from the main survey database. These variables were modelled as potential determinants of HIV-NCD comorbidities. HIV-NCD comorbidity was defined as being HIV-positive and having at least one non-communicable disease. χ² tests and logistic regression analyses were performed to identify the determinants of HIV-NCD comorbidity. Results: Among the 1850 PLWH included in the analysis, 70.2% were female, 63.0% resided in rural areas and 70.0% had attained primary education. Hypertension was the most prevalent chronic condition (3.3%), followed by lung disease (1.1%), cancer/tumour (1.0%) and heart disease (1.0%), respectively. The overall prevalence of HIV-NCD comorbidity was 6.7% (95% CI 5.4% to 8.3%). Female participants had significantly higher odds of HIV-NCD comorbidity (adjusted OR (aOR)=1.9; 95% CI 1.2 to 3.1; p=0.010). Age was also strongly linked to comorbidity, with individuals aged 45-54 years (aOR=9.4; 95% CI 2.7 to 33.4; p=0.001) and those aged ≥55 years (aOR=16.1; 95% CI 4.4 to 58.3; p<0.001) showing higher odds than those aged 15-24 years. Conclusions: HIV-NCD comorbidities are common among PLWH. Female sex and older age significantly increase the risk, emphasising the importance of tailored interventions for prevention, early detection and integrated care strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.